Colinz Laboratories Limited responded to a letter from the BSE Limited Surveillance Department dated 1st June 2026 regarding significant movement in the company's share price.
The company confirmed that it has been promptly disclosing all material events, information, and developments to the Stock Exchanges in compliance with Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Specifically, the company stated that to the best of its knowledge, there is no unpublished price-sensitive information, material event, or pending announcement that may have a bearing on the movement in the price or volume of the company's shares.
The company attributed the recent movement in its share price to being "purely MARKET-DRIVEN EXERCISE" based on market conditions and investor perception, explicitly stating that the company has no role in the price movement.
Colinz Laboratories reaffirmed its commitment to complying with all applicable disclosure requirements and continuing to inform the Stock Exchanges of any material information as and when required.
The document was signed on behalf of Colinz Laboratories Limited and includes the company's corporate identification number (CIN: L24200MH1986PLC041128) and corporate office address in Mumbai.